Genomics of prostate cancer: is there anything to "translate"? (Q36358322)

13 August 2017

1 reference

title

Genomics of prostate cancer: is there anything to "translate"? (English)

1 reference

13 August 2017

0 references

1 reference

László Kopper

1

1 reference

13 August 2017

József Tímár

series ordinal

2

1 reference

13 August 2017

publication date

31 December 2005

1 reference

Pathology and Oncology Research

13 August 2017

published in

1 reference

13 August 2017

volume

11

1 reference

13 August 2017

issue

4

1 reference

13 August 2017

page(s)

197-203

1 reference

Myc confers androgen-independent prostate cancer cell growth

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02893851

Prostate cancer and the genomic revolution: Advances using microarray analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02893851

Gene expression profiling predicts clinical outcome of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02893851

Hepsin promotes prostate cancer progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02893851

Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02893851

Dysregulation of the annexin family protein family is associated with prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02893851

Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.

21 January 2018

1 reference

12 December 2020

Prognostic Significance of Serum Soluble Fas Level and Its Change during Regression and Progression of Advanced Prostate Cancer

1 reference

12 December 2020

Human prostate carcinoma cells express functional alphaIIb(beta)3 integrin

1 reference

12 December 2020

Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer

1 reference

12 December 2020

Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes

1 reference

12 December 2020

Unravelling the genetics of prostate cancer

1 reference

12 December 2020

Interpretation of expression-profiling results obtained from different platforms and tissue sources: examples using prostate cancer data.

1 reference

12 December 2020

Pathological and molecular aspects of prostate cancer

1 reference

12 December 2020

Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers

1 reference

12 December 2020

Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.

1 reference

12 December 2020

Gene expression profiles of genistein-treated PC3 prostate cancer cells

1 reference

12 December 2020

Mechanisms of bone metastasis

1 reference

12 December 2020

Prognostic significance of the nadir prostate specific antigen level after hormone therapy for prostate cancer.

1 reference

12 December 2020

Serum interleukin-8 is elevated in men with prostate cancer and bone metastases

1 reference

12 December 2020

Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells

1 reference

12 December 2020

Tissue polypeptide-specific antigen (TPS) determinations before and during intermittent maximal androgen blockade in patients with metastatic prostatic carcinoma

1 reference

12 December 2020

CYP3A4 polymorphisms - potential risk factors for breast and prostate cancer: a huge review

1 reference

12 December 2020

Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia

1 reference

12 December 2020

Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence

1 reference

12 December 2020

GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer

1 reference

12 December 2020

Involvement of growth factor receptors of the epidermal growth factor receptor family in prostate cancer development and progression to androgen independence

1 reference

12 December 2020

Androgen receptor mutations in high-grade prostate cancer before hormonal therapy.

1 reference

12 December 2020

A new member of the growing family of metastasis suppressors identified in prostate cancer

1 reference

12 December 2020

The androgen axis in recurrent prostate cancer

1 reference

12 December 2020

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature

1 reference

12 December 2020

Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer

1 reference

12 December 2020

MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion

1 reference

12 December 2020

Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

1 reference

12 December 2020

Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues

1 reference

12 December 2020

Comparison of methods of microvascular staining and quantification in prostate carcinoma: relevance to prognosis

1 reference

12 December 2020

Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer

1 reference

12 December 2020

Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma

1 reference

12 December 2020

Delineation of prognostic biomarkers in prostate cancer

1 reference

12 December 2020

Genetic polymorphisms and prostate cancer risk

1 reference

12 December 2020

Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array.

1 reference

12 December 2020

Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease

1 reference

12 December 2020

DNA methylation in prostate cancer

1 reference

12 December 2020

Molecular biology of prostate cancer

1 reference

12 December 2020

Prognostic significance of angiogenesis in clinically localized prostate cancer (staining for Factor VIII-related antigen and CD34 Antigen

1 reference

12 December 2020

Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer

1 reference

12 December 2020

Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer

1 reference

12 December 2020

Proteomics in prostate cancer

1 reference

12 December 2020

Prostate cancer: potential targets of anti-proliferative and apoptotic signaling pathways

1 reference

12 December 2020

Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential

1 reference

12 December 2020

Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer.

1 reference

12 December 2020

Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis

1 reference

12 December 2020

Environmental, genetic, and molecular features of prostate cancer

1 reference

12 December 2020

Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications.

1 reference

12 December 2020

Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.

1 reference

12 December 2020

Germline mutation analysis of the androgen receptor gene in Finnish patients with prostate cancer.

1 reference

12 December 2020

Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer

1 reference

12 December 2020

Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer

1 reference

12 December 2020

Molecular pathology of prostate cancer

1 reference

12 December 2020

Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer

1 reference

12 December 2020

HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial

1 reference

12 December 2020

Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs

1 reference

12 December 2020

E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.

1 reference

12 December 2020

Molecular mechanisms of prostate cancer

1 reference

12 December 2020

The relation of p53 protein nuclear accumulation and angiogenesis in human prostatic carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02893851

1 reference

13 August 2017

1 reference